SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 331 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $15,622 | -20.5% | 162 | 0.0% | 0.00% | -33.3% |
| Q3 2023 | $19,638 | +5.9% | 162 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $18,552 | -16.9% | 162 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $22,328 | +106223.8% | 162 | 0.0% | 0.00% | +33.3% |
| Q4 2022 | $21 | -99.9% | 162 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $18,000 | +50.0% | 162 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $12,000 | -7.7% | 162 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $13,000 | -13.3% | 162 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $15,000 | 0.0% | 162 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $15,000 | +25.0% | 162 | 0.0% | 0.00% | +50.0% |
| Q1 2021 | $12,000 | -57.1% | 162 | 0.0% | 0.00% | -60.0% |
| Q4 2020 | $28,000 | +21.7% | 162 | 0.0% | 0.01% | +25.0% |
| Q3 2020 | $23,000 | -11.5% | 162 | 0.0% | 0.00% | -20.0% |
| Q2 2020 | $26,000 | +62.5% | 162 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $16,000 | – | 162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |